Federal health officials in the United States are taking proactive measures to combat a potential outbreak of the bird flu strain currently circulating in dairy cows. With at least 36 herds across nine states already infected, concerns are mounting over the possibility of the virus mutating and spreading to humans.
In response, officials have two vaccines ready that could be quickly distributed if needed. These vaccines have shown promising results in studies, offering good cross-protection against the current outbreak. The government has already stockpiled hundreds of thousands of prefilled syringes and vials in preparation for a potential mass vaccination campaign.
Despite the lack of evidence of person-to-person transmission of H5N1, health officials are closely monitoring over 100 people, mostly farm workers, for any signs of infection. The U.S. has the capacity to produce over 100 million doses of the vaccine within a few months, far exceeding the estimated 50 million people who would need it.
However, questions remain about the effectiveness of the vaccines and their ability to prevent severe illness. The traditional vaccine technology used may also require FDA approval before distribution, further complicating efforts to combat the virus.
Additionally, vaccine skepticism and fatigue could pose challenges to any future vaccination campaigns. The government currently has contracts with manufacturers for pandemic influenza vaccines, with one candidate vaccine showing promising results in phase 2 studies.
As the situation continues to evolve, federal health officials are prepared to act swiftly to prevent the spread of H5N1 to humans. Stay tuned for updates on World News Live.
“Infuriatingly humble tv expert. Friendly student. Travel fanatic. Bacon fan. Unable to type with boxing gloves on.”